Analytical Data
-
Gene name
CATHL1
- Application
-
Alternative Names
Bactenecin-1 （Bac1）（Cyclic dodecapeptide）
-
Species
Bovine
-
Source
HEK293
-
Tag
C- hFC-Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P22226
-
Expression Region
144-155aa
-
Molecular Weight
30.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CATHL1 (Cathelicidin Antimicrobial Peptide Human 1) is an important component of the innate immune system, known for its antimicrobial properties and role in host defense against pathogens. It is a member of the cathelicidin family of peptides, characterized by their ability to disrupt microbial membranes and modulate immune responses. The interest in CATHL1 research has grown in recent years due to its potential therapeutic applications in treating infections, particularly in an era of increasing antibiotic resistance. Researchers are exploring the mechanisms by which CATHL1 exerts its antimicrobial effects and its interactions with various immune cells to better understand its role in inflammation and infection. Recombinant CATHL1 protein production facilitates the study of its structural and functional characteristics, enabling detailed investigations into its pharmacological potential. Moreover, understanding the biological activities of CATHL1 can pave the way for novel antimicrobial therapies and the development of peptide-based drugs. As research advances, CATHL1 is emerging as a focal point in the quest for innovative strategies to combat resistant bacterial strains and improve immune responses, highlighting the significance of this protein in both fundamental immunology and applied biomedical research.
